Antiglucocorticoid steroids for the treatment of anxiety disorders

- Akzo Nobel N.V.

The invention relates to the use of antiglucocorticoid steroids for the manufacture of a pharmaceutical composition for the treatment of anxiety disorders.

Skip to:  ·  Claims  ·  References Cited  · Patent History  ·  Patent History

Claims

1. A method for the treatment of anxiety disorders, comprising administering an anxiolytically effective amount of at least one antiglucocorticoid steroid.

2. The method according to claim 1, wherein the antiglucocoticoid steroid has the general formula ##STR7## wherein R.sub.1 is H, CH.sub.3, unsubstituted or OH or halogen substituted CH.sub.2.dbd.CH--CH.sub.2 or CH.dbd.C--CH.sub.2, or an aryl, arylthio or arylmethyl group, the aryl moieties of which may optionally be substituted with (C1-C6) alkyl, (C1-C6) alkoxy, OH, halogen or CF.sub.3, or R.sub.1 together with R.sub.7 is a bond;

R.sub.2 is H, (C1-C6) alkyl or an aryl group optionally substituted with a group selected from (C1-C6) acyl, (C1-C6) alkoxy, (C1-C6) thioalkoxy, --O--(CH.sub.2).sub.n --O--, n being 1 or 2, and ##STR8## X and Y each being independently H or a group selected from (C1-C6) alkyl and (C1-C6) acyl, or R.sub.2 together with R.sub.7 is a bond;
R.sub.3 is (C1-C6) alkyl;
R.sub.4 is H, OH, (C1-C6) alkoxy, (C1-C6) acyloxy, a group selected from (C1-C6) alkyl, (C1-C6) alkenyl and (C1-C6) alkynyl, each of which group may be substituted with hydroxy, oxo, halogen, azido or cyano, or --C.tbd.C-phenyl, the phenyl group of which may optionally be substituted with S--(O)m--(C1-C6) alkyl, m being 1 or 2, or with ##STR9## X and Y each being independently H or a group selected from (C1-C6) alkyl and (C1-C6) acyl, or X and Y together with the nitrogen to which they are bonded form a ring;
R.sub.5 is OH or a group selected from (C1-C6) acyloxy, (C1-C6) alkoxy or (C1-C6) acyl, each of which group may optionally be substituted with hydroxy, (C1-C6) alkoxy, (C1-C6) acyloxy or halogen; or
R.sub.4 and R.sub.5 together with the carbon atom to which they are bonded form a 5- or 6-membered ring system;
R.sub.6 is H or methyl optionally substituted with hydroxy or (C1-C6) alkoxy; and
R.sub.7 forms a bond with either R.sub.1 or R.sub.2.
Referenced Cited
U.S. Patent Documents
5232917 August 3, 1993 Bolger et al.
Other references
  • D.F. Papolos, Brain Research, 615 (1993) 304-309. S.M. Korte et al., Hormones and Behavior, 27:167-183 (1993). H.D. Veldhuis et al., European Journal of Pharmacology, 115(1985) 211-217. E.R. De Kloet et al., Neuroendocrinology, 47:109-115 (1988).
Patent History
Patent number: 5741787
Type: Grant
Filed: Jan 18, 1996
Date of Patent: Apr 21, 1998
Assignee: Akzo Nobel N.V. (Arnhem)
Inventor: Bernardus Wynand Mathijs Marie Peeters (Herpen)
Primary Examiner: James H. Reamer
Attorneys: William M. Blackstone, Mary E. Gormley
Application Number: 8/581,631